Blood test shows high accuracy in detecting stage I non-small cell lung cancer

Abstract Background In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed e...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Cherylle Goebel, Christopher L. Louden, Robert Mckenna, Osita Onugha, Andrew Wachtel, Thomas Long
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2020-02-01
Reeks:BMC Cancer
Onderwerpen:
Immunoassay
Early stage lung cancer
Detection
Biomarkers
Proteomics
Diagnostic tests
Online toegang:http://link.springer.com/article/10.1186/s12885-020-6625-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items